Homocysteine is a thiol aminoacid synthesized during the metabolism of methionine.
Increased plasma levels of homocysteine can be the result of mutations in the enzymes …

Hyperhomocysteinemia or systemic elevation of the amino acid homocysteine is a common
metabolic disorder that is considered to be a risk factor for ischemic stroke. However, it is still …

Hyperhomocysteinemia (HHcy) is recognized as an independent risk factor for various
significant medical conditions, yet controversy persists around its assessment and …

Hyperhomocysteinemia is recognized as a risk factor for several diseases, including
cardiovascular and neurological conditions. Homocysteine (HCys) is a key metabolite …

Hyperhomocysteinemia/Homocysteinuria is characterized by an increased level of toxic
homocysteine in the plasma. The plasma concentration of homocysteine is 5–15 μmol/L in …

In the last 10 years, homocysteine has been regarded as a marker of cardiovascular disease
and a definite risk factor for many other diseases. Homocysteine is biosynthesized from …

Homocysteine is a sulphur‐containing non‐proteinogenic amino acid.
Hyperhomocysteinaemia (HHcy), the pathogenic elevation of plasma homocysteine as a …

Homocysteine (Hcy) is a thiol group containing the amino acid, which naturally occurs in all
humans. Hcy is degraded in the body through two metabolic pathways, while a minor part is …

Epidemiological studies established that elevated homocysteine, an important intermediate
in folate, vitamin B12, and one carbon metabolism, is associated with poor health, including …

Nutritional and genetic deficiencies of folate and vitamin B 12 lead to elevation of cellular
homocysteine (Hcy), which translates in increased plasma Hcy. The sources and role of …